ArticleJournal of microbiology and biotechnology2025
Antipruritic Effect of 2,3-Dehydrosilybin in Glial Cells and Chloroquine-Treated Mice.
Article in Journal of microbiology and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pruritus is an inflammatory skin disorder that reduces the patient's quality of life. Meanwhile, 2,3-dehydrosilybin (DHS) belongs to a class of flavonolignans derived from milk thistle seeds, and is known to have anticancer, hepatoprotective, antioxidant, and angiogenic effects. In the current study, the inhibitory effect of DHS on pruritus was investigated in lipopolysaccharide (LPS)-stimulated microglia, IL-31- and IL-6-treated astrocytes, and chloroquine-treated mice. DHS was shown to suppress pruritus-related cytokines IL-31 and IL-6 in LPS-treated microglia. Moreover, DHS inhibited activation of MAPKs (p38, ERK, and JNK) in LPS-stimulated microglia. Furthermore, DHS prevented activation of STAT3 and LCN-2 production in IL-31- and IL-6-treated astrocytes. In addition, DHS inhibited scratching and GFAP expression in chloroquine-treated mice. These results suggest that DHS may prevent and/or treat pruritus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.